SGLT2 Inhibitor No Help for ICU Patients With Acute Organ Dysfunction

MedPage Today) — Adding an SGLT2 inhibitor to standard care did not improve clinical outcomes in critically ill patients with acute organ dysfunction, an open-label randomized trial involving intensive care units (ICUs) in Brazil found.
In the…